I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| naive B cell | 8 studies | 18% ± 2% | |
| B cell | 3 studies | 19% ± 1% | |
| immature B cell | 3 studies | 19% ± 0% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| naive B cell | 8 studies | 18% ± 2% | |
| B cell | 3 studies | 19% ± 1% | |
| immature B cell | 3 studies | 19% ± 0% |
Insufficient scRNA-seq data for expression of CLEC17A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lymph node | 0% | 0 | 0 / 0 | 100% | 78.60 | 29 / 29 |
| spleen | 100% | 1018.00 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 1661.43 | 909 / 929 | 0% | 0 | 0 / 0 |
| brain | 44% | 19.06 | 1175 / 2642 | 49% | 2.47 | 345 / 705 |
| lung | 48% | 13.47 | 279 / 578 | 31% | 0.92 | 356 / 1155 |
| intestine | 42% | 140.55 | 410 / 966 | 12% | 1.36 | 61 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 49% | 1.94 | 22 / 45 |
| kidney | 25% | 13.43 | 22 / 89 | 23% | 0.55 | 210 / 901 |
| breast | 12% | 2.70 | 57 / 459 | 23% | 0.90 | 252 / 1118 |
| esophagus | 11% | 3.48 | 164 / 1445 | 21% | 0.61 | 39 / 183 |
| pancreas | 2% | 0.61 | 8 / 328 | 30% | 1.73 | 53 / 178 |
| stomach | 12% | 4.19 | 44 / 359 | 20% | 1.66 | 57 / 286 |
| prostate | 22% | 6.92 | 54 / 245 | 7% | 0.16 | 36 / 502 |
| thymus | 15% | 19.26 | 96 / 653 | 14% | 0.77 | 86 / 605 |
| bladder | 14% | 6.90 | 3 / 21 | 9% | 0.64 | 47 / 504 |
| skin | 1% | 0.20 | 22 / 1809 | 21% | 1.40 | 101 / 472 |
| liver | 14% | 2.69 | 31 / 226 | 4% | 0.25 | 16 / 406 |
| adipose | 12% | 5.77 | 142 / 1204 | 0% | 0 | 0 / 0 |
| ovary | 5% | 0.80 | 9 / 180 | 5% | 0.09 | 20 / 430 |
| uterus | 3% | 0.51 | 5 / 170 | 5% | 0.15 | 25 / 459 |
| blood vessel | 7% | 7.15 | 87 / 1335 | 0% | 0 | 0 / 0 |
| heart | 4% | 1.44 | 35 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 2% | 0.28 | 4 / 258 | 1% | 0.01 | 2 / 230 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
| muscle | 1% | 0.09 | 5 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0044419 | Biological process | biological process involved in interspecies interaction between organisms |
| GO_0009986 | Cellular component | cell surface |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0042806 | Molecular function | fucose binding |
| GO_0005537 | Molecular function | D-mannose binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | CLEC17A |
| Protein name | C-type lectin domain containing 17A C-type lectin domain family 17, member A (Prolectin) |
| Synonyms | |
| Description | FUNCTION: Cell surface receptor which may be involved in carbohydrate-mediated communication between cells in the germinal center. Binds glycans with terminal alpha-linked mannose or fucose residues. . |
| Accessions | Q6ZS10 ENST00000551730.1 ENST00000417570.6 [Q6ZS10-1] ENST00000547437.5 [Q6ZS10-3] ENST00000339847.9 [Q6ZS10-2] F8W1T8 |
